New Delhi : CURO Biosciences Private Limited, operating under the name ErlySign, has raised ₹16 crore in pre-Series A funding from investor Ashish Kacholia. The funding, facilitated by DerivativeSaint, a private equity and venture capital advisory firm, highlights the company’s focus on early cancer detection. This development positions CURO Biosciences to contribute to the global … Read more
Hyderabad: Innominds announces its partnership with SCIINV Biosciences to introduce AMRx, an advanced AI/ML-driven digital diagnostic tool designed to combat the growing threat of antimicrobial resistance (AMR). This innovative tool promises to revolutionise the detection and treatment of antibiotic-resistant infections without the need for traditional cultures. The World Health Organization has identified AMR as one … Read more
New Delhi: Artificial intelligence (AI) guided screening has identified three anti-aging drug candidates targeting ‘zombie’ cells, a significant milestone for both longevity research, researchers revealed. The team from the Massachusetts Institute of Technology (MIT) and the Broad Institute of MIT and Harvard, described the AI-guided screening of more than 800,000 compounds to reveal three drug … Read more
California: Crosscope Inc. and Farcast Bioscience LLC have developed a unique and differentiated human tumour histoculture platform that can preserve the entire architecture of the human tumour microenvironment. The two companies will work together for the prospective evaluation of OrionAI—a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours, beginning with … Read more